Chemotherapy definitions and policies for thymic malignancies Journal Article
| Authors: | Girard, N.; Lal, R.; Wakelee, H.; Riely, G. J.; Loehrer, P. J. |
| Article Title: | Chemotherapy definitions and policies for thymic malignancies |
| Keywords: | cancer survival; treatment response; prednisone; cancer recurrence; cisplatin; doxorubicin; cancer growth; multimodality cancer therapy; treatment duration; antineoplastic agents; paclitaxel; postoperative care; chemotherapy; cancer staging; nuclear magnetic resonance imaging; cancer palliative therapy; carboplatin; computer assisted tomography; etoposide; radiotherapy; cyclophosphamide; vincristine; practice guideline; biopsy; ifosfamide; cardiovascular risk; cardiotoxicity; practice guidelines as topic; epirubicin; terminology as topic; octreotide; thymoma; pemetrexed; thymic carcinoma; thymus neoplasms; thymus cancer; corticosteroids; corticosteroid therapy; thymic hyperplasia; thymus hyperplasia; policy making |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 6 |
| Issue: | 7 Suppl. 3 |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2011-01-01 |
| Start Page: | S1749 |
| End Page: | S1755 |
| Language: | English |
| DOI: | 10.1097/JTO.0b013e31821ea5f7 |
| PROVIDER: | scopus |
| PUBMED: | 21847058 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 17 August 2011" - "Source: Scopus" |
